Singular Genomics Systems, Inc.

NasdaqGS:OMIC Stock Report

Mkt Cap: US$177.1m

Singular Genomics Systems Future Growth

How is Singular Genomics Systems forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

Future Growth Score

2/6

Future Growth Score 2/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


-1.3%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqGS:OMIC - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2025107-97N/AN/A1
12/31/202449-101-94-934
12/31/202313-110-90-985
9/30/2022N/A-90-89-83N/A
6/30/2022N/A-83-79-72N/A
3/31/2022N/A-97-68-62N/A
12/31/2021N/A-99-57-52N/A
9/30/2021N/A-87-46-43N/A
6/30/2021N/A-77-41-39N/A
3/31/2021N/A-47-31-29N/A
12/31/2020N/A-28-26-25N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: OMIC is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: OMIC is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: OMIC is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: OMIC's revenue (88.9% per year) is forecast to grow faster than the US market (7% per year).

High Growth Revenue: OMIC's revenue (88.9% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: OMIC is forecast to be unprofitable in 3 years.


Discover growth companies